We fight cancer
Our mission is to identify innovative agents for clinical development in areas of unmet medical needs in Oncology.
From the “Discovery” phase onwards to clinical phase II, our aim is to advance the way in which cancer is treated and to contribute towards making cancer a more manageable disease for caregivers and patients.
Our quest is therefore devoted to the understanding of cancer pathogenetic and maintenance mechanisms, instrumental to discover and develop novel molecules aimed at those mechanisms and able to show benefit in patients.
We are a fully integrated Group in which the Oncology scientists involved in new drug discovery and development operate in close collaboration with the other Divisions of Nerviano Medical Sciences in a stimulating professional environment.
Read our publications